Recent placebo literature provides the scientific basis for the different psychological factors that influence the outcome of a medical treatment. The aim of the present review is to summarize the recent findings of placebo research offering useful tools for everyday medical routine.
INTRODUCTION
In the course of history, medical practice has considerably changed. The ancient and primitive medicine of shamans and priests was psychological in nature, and centered on words and rituals. The outcome of those psychological treatments was in many cases remarkable and aimed to treat the person. Modern medicine, also called 'evidence-based', consists in the administration of specific drugs and treatments, which first have to be tested in a randomized, double-blinded, placebo-controlled trial. The healing effect of these chemical treatments is surely important; nonetheless, it is aimed at treating the disease rather than the person. In spite of the clear advantage of modern medicine, we are now witnessing increasing interest and awareness of the importance of the psychological factors that surround every medical act. This knowledge comes from different fields. On the one hand, palliative medicine is promoting a healing process which aims to take care of the person rather than to cure the disease: it emphasizes the care of the personal, physical and social needs of the patient, the quality of life, and the relationship and communication between doctor and patient. On the other hand, research about the placebo effect has demonstrated the crucial role of the psychosocial context, leading to a comprehensive model of medicine that includes both chemical and psychological processes. Indeed, any therapeutic treatment, be it pharmacological or procedural, can be described as the result of two different processes, both contributing to the therapeutic benefit: the specific chemical process, that is, the action of the pharmacological agent (e.g. morphine), and the ritual process, that is, the psychosocial context surrounding the treatment, including the act of its administration (e.g. the color of the morphine pill, the words used to describe the features of the drug, etc.). In a placebo treatment, the active drug is replaced with an inert substance (placebo) and only the ritual process is present. Accordingly, the placebo effect and its opposite nocebo effect, can be defined as the neurobiological modifications that occur in the patient's brain after the simulation of a therapy [1 && ]. Remarkable placebo effects have been shown in several conditions, such as pain [2 & ,3,4], itch [5] , Parkinson's disease [6] [7] [8] [9] , depression [10, 11] , anxiety [12, 13] , immune functions [14] [15] [16] [17] , motor performance [18] [19] [20] , and asthma [21 && ]. Modern neuroscience has focused on two main aspects related to the placebo effect: first, the identification of the placebo underpinnings, such as the systems and the brain regions responsible for the placebo phenomenon, and second, the implications of placebo research for clinical practice. For example, the opioid system [22] [23] [24] [25] [26] 27 && ] and the antiopioid cholecystokinin (CCK) system [28, 29] have been found to be involved. In addition, recent work has also shown that the endocannabinoid system mediates the nonopioid component of placebo analgesia [30 && ], and dopaminergic and serotoninergic systems have been documented in Parkinson's disease and social anxiety, respectively [6, 7, [9] [10] [11] [12] [13] . Neuroimaging studies have also demonstrated that the placebo effect occurs along with the activation of a complex neural network, with prefrontal areas playing a crucial role [25,31-35,36 & ,37 & ]. Rather than focusing on these neurobiological, neuropharmacological, and neuroanatomical advances of placebo research, which are described in detail in other reviews [38] [39] [40] [41] , in the present article we want to discuss some practical implications which have emerged in the course of the past years. We believe that these implications have the potential to positively affect the practice of those health professionals who work in the palliative care setting, who have to use the appropriate words, and who have to adopt the adequate attitudes and behaviors in their everyday medical practice.
WORK WITH EXPECTATIONS
The expectation of an outcome represents a crucial factor in every medical treatment. In fact, a therapeutic procedure produces an effect partly because of the patient's expectations. These can be fostered by an internal locus of control (e.g. 'I believe in myself and with the help of the drug I can cope with the disease') or by an external locus of control (e.g. 'The doctor told me that the drug is so powerful that I will get better soon') [42] . Indeed, according to the cognitive theory of placebo, cognitive processes such as expectancy, anticipation, motivation, desire, belief, and optimism [43] are at play in the healing process. These are conscious processes activated by several factors, such as verbal instructions, patient-doctor interaction, and emotional arousal of the patient. Different studies have investigated the role of these factors in both the laboratory and the clinical contexts. Recently, in the laboratory setting, Van Laarthover et al. [5] have manipulated expectations through verbal suggestions in a new experimental model of itch. Different somatosensory stimuli were delivered along with high (nocebo) or low (control) expectations of itch. As expected, following the suggestions of itch increase the patients experienced significantly higher levels of itch compared with controls. The power of expectation through verbal suggestions has been documented also in clinical conditions. In a doubleblinded study, patients with asthma were randomly assigned to receive an active treatment with an albuterol (or salbutamol) inhaler, a placebo inhaler, sham acupuncture, or no intervention [21 && ]. Even if albuterol administration resulted in a 20% increase in the forced expiratory volume (FEV 1 ), the patients reported no subjective differences between albuterol and placebo treatments. In terms of subjective outcome therefore, the placebo effect proved equivalent to the drug effect, confirming the importance of the patient's expectation about therapy effectiveness. In another study with Parkinson's disease patients, participants were told that they had a specific probability (25, 50, 75, [9] . Significant dopamine release in the nigrostriatal and mesoaccumbens pathways occurred when the declared probability of receiving active medication was 75%, suggesting a close relationship between the improvement belief and the resultant clinical benefit. In a different study, it was demonstrated that the open-label administration of a placebo in irritable bowel syndrome (IBS) patients produces an improvement in IBS symptoms when patients know that 'the placebo, at least in some circumstances, works as a real drug through the release of endogenous opioids' [44] . Therefore, the knowledge and the understanding of a treatment boost positive expectations which, in turn, lead to symptom amelioration.
USE EMPATHY AND COOPERATION
In addition to the importance of knowing and understanding the effect of a treatment, a second important aspect is represented by the patient's needs. There are both cognitive and affective needs, the latter being aimed at creating an empathic doctor-patient relationship [45] . Kelley et al. [46] investigated the affective needs in an experimental design with placebo acupuncture. IBS patients were divided into three groups. Two groups were treated with placebo acupuncture with either a warm empathic interaction or a neutral interaction: the only difference between the two conditions was the quality of interpersonal interaction between the practitioner and the patient (warm and empathic or neutral and minimal). A third group (waiting list group) was periodically monitored, but no treatment was delivered. A single-outcome measure was constructed by combining four different IBS symptom scales. The empathic interaction produced an improvement compared with the neutral or waiting-list interactions. This study highlights the importance of the clinical interaction during the healing process but does not differentiate between the emotional and the cognitive needs. The difference between these two aspects has been documented in a recent work [47] , in which either empathic or cold communication was combined with positive or uncertain expectations about the effect of an analgesic on menstrual pain, in a 2 Â 2 randomized controlled trial. Only warm and empathic communication with positive expectation led to a relevant decrease in anxiety state. Even if no measures of pain rating were reported, the key role of communication style is nonetheless documented, suggesting important implications for medical practice.
In the last decade, the relationship between doctor and patient has considerably evolved. From a directive approach, in which the doctor prescribed a specific cure to the patient without discussion, a better refinement of the informed consent has increased the patient involvement in the therapeutic process, leading to a more cooperative relationship, embracing both cognitive and emotional needs. Rose et al. [48 & ] studied the effect of this cooperative relationship by testing the effect of the treatment choice. Participants underwent the cold pressor test for pain tolerance following the application of a novel analgesic (actually a placebo). They were split in three groups: a 'choice' group was permitted to choose the analgesic treatment to be used during the pain task, a 'no-choice' group received a random treatment, and a control group was administered a treatment without eliciting expectations or giving a choice. Pain ratings were obtained during the test at different times, and after the test by means of a questionnaire. The choice group experienced less pain during and after the test compared with the no-choice and control groups, and the authors suggested a possible involvement of anxiety mechanisms. These results are useful especially in light of the recent emphasis on 'patientoriented' medicine [49] . Indeed, the authors suggest that one positive consequence of the enhanced involvement of the patient in a therapy is a greater placebo response. On the whole, the increase of patients' expectations and the use of a cooperative and empathic approach clearly enhance medical treatments.
USE PREVIOUS EXPERIENCES AND LEARNING
The placebo literature has taught us that, in some circumstances, the healing process can be due to classical conditioning. For example, an analgesic is a significant event (unconditioned stimulus) that induces per se a natural response such as analgesia (unconditioned response), whereas the physical features of the analgesic (e.g. shape, color, and taste) or contextual cues that accompany its administration (e.g. hospital environment, white coats, or syringes) are neutral stimuli (conditioned stimuli) that are not related to a specific innate behavior. However, after repeated associations between the conditioned and unconditioned stimuli (acquisition phase), the conditioned stimuli alone (evocation phase) can evoke the therapeutic benefit (conditioned response). Following this schema, the placebo effect can be considered a learned conditioned response that takes place after the repeated pairing between the conditioned stimuli and the unconditioned stimulus [50] . As recently shown, the higher the number of unconditioned stimulus-conditioned stimuli pairings, the stronger the placebo response [3] . The authors delivered tactile and painful stimuli on the dorsum of the foot and exposed the volunteers to one or four conditioning sessions in which decreased (placebo) or increased (nocebo) perceived intensities (unconditioned stimulus) were induced and paired with green or red lights (conditioned stimuli), respectively. After four conditioning trials, the patients experienced more robust placebo and nocebo responses that lasted for the entire experiment. This study suggests that prior exposure to effective treatments may be clinically important, inducing long-lasting placebo responses. At the same time, avoiding negative experiences is crucial, in order to prevent the occurrence of nocebo effects.
In a clinical setting, Ader et al. [51] used a conditioning procedure to reduce the drug regimen, while maintaining the symptoms improvement. Following an acquisition phase during which a corticosteroid therapy was given, patients with psoriasis were treated for 8 weeks in different ways: a first group was administered a full medication for the entire experiment (standard therapy group without conditioning), a second received the full medication for 25-50% of the time and a placebo medication for the remaining time (conditioning group with partial reinforcement), a third group was treated with 25-50% of the full dose for the entire experiment (dose control group). A similar improvement was observed in the standard therapy and conditioning groups by using the Psoriasis Severity Scale index, whereas the dose control group showed severe worsening. This study demonstrates that the intermittent reinforcement, consisting in the combined administration of real drugs and placebos, is capable of producing beneficial effects, with the further advantage of reducing possible side-effects often associated with a long-lasting pharmacological treatment [52] .
ENHANCE THE KNOWLEDGE ABOUT THE THERAPY AND AVOID SYMPTOM WORSENING
In current medical practice, the doctor usually notifies the patient about the timing and effects of a treatment: this modality can be defined 'open' or 'expected', because the patient is aware of the treatment administration and expects the therapeutic benefit. Conversely, when the patient receives the treatment without information about its administration (e.g. when the therapy is delivered by a computer-controlled infusion pump), the condition can be defined 'hidden' or 'unexpected', because no expectations about the therapeutic outcome are elicited. Of course, in both the open and hidden conditions the same analgesic is administered, so that the only difference between the two conditions is represented by the patient's expectations of clinical improvement [53 && ]. In a recent fMRI study [54 && ], it was shown that a hidden administration of an analgesic induced pain decrease, associated with decreased activity in several pain matrix regions, such as the primary somatosensory cortex, the insula, the anterior cingulate cortex, and the thalamus. However, the effect doubled after an open administration, with increased activity in the pregenual anterior cingulate cortex and the dorsolateral prefrontal cortex. Therefore, in this study the psychological component, represented by the expectations of being treated, enhanced the pharmacological effect of the analgesic.
In another study, Bjorkedal and Flaten [55] used caffeine as an active placebo, that is, a drug without effects on the symptom under investigation but mimicking the side-effect of the active treatment. A total of 0 or 4 mg/kg of caffeine was administered along with suggestions of analgesia (placebo and active placebo groups, respectively) or with no information (control or caffeine group, respectively) about the administration of an analgesic. The results showed that 4 mg/kg of caffeine reduced pain, and that the expectation of analgesic administration produced longer analgesia compared with the no-information group. As suggested by the authors, the drug might have provided an interoceptive cue interacting with the verbal information.
Overall, the open-hidden design highlights the key role of medical rituals and expectations.
Whereas the open administration of a treatment boosts the pharmacological effect of the drug, the open interruption of a therapy may lead to opposite effects, for the ritual of interruption may induce negative expectations of worsening. Interestingly, the relapse of symptoms in both pain and anxiety is faster with an open compared with a hidden interruption [53 && ]. Psychological adverse reactions (nocebo effects) can also be produced in clinical practice by the informed consent, in which the possible occurrence of side-effects is usually described in some detail [56] . It is therefore necessary to find a compromise between the opposing needs of information disclosure and nocebo effects minimization.
CONCLUSION
The placebo effect is an interesting topic for neuroscience because it represents a good example of the top-down influence of cognitive factors on behavior. Health professionals often know that empathic communication and cooperation, attention to the context, patients' expectation, and previous experiences are important factors to be considered for a positive outcome. This common knowledge is now given scientifically sound ground by the findings of placebo research, which can be incorporated into a sort of 'vade mecum' for better clinical practice.
